Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Tuberculosis

  Free Subscription


29.08.2022

1 Clin Infect Dis
3 Emerg Infect Dis
11 Int J Tuberc Lung Dis
2 J Infect
3 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Clin Infect Dis

  1. KAGUJJE M, Kerkhoff AD, Nteeni M, Dunn I, et al
    The performance of computer-aided detection digital chest X-ray reading technologies for triage of active Tuberculosis among persons with a history of previous Tuberculosis.
    Clin Infect Dis. 2022 Aug 25. pii: 6675069. doi: 10.1093.
    PubMed         Abstract available


    Emerg Infect Dis

  2. LAEMMLE-RUFF I, Graham SM, Williams B, Horyniak D, et al
    Detecting Mycobacterium tuberculosis Infection in Children Migrating to Australia.
    Emerg Infect Dis. 2022;28:1833-1841.
    PubMed         Abstract available

  3. CAMPBELL JR, Nsengiyumva P, Chiang LY, Jamieson F, et al
    Costs of Tuberculosis at 3 Treatment Centers, Canada, 2010-2016.
    Emerg Infect Dis. 2022;28:1814-1823.
    PubMed         Abstract available

  4. KHERABI Y, Frechet-Jachym M, Rioux C, Yazdanpanah Y, et al
    Revised Definitions of Tuberculosis Resistance and Treatment Outcomes, France, 2006-2019.
    Emerg Infect Dis. 2022;28:1796-1804.
    PubMed         Abstract available


    Int J Tuberc Lung Dis

  5. KRAEF C, Yedilbayev A, Seguy N, Bentzon A, et al
    Uptake of the lateral flow urine LAM test in Europe and Central Asia.
    Int J Tuberc Lung Dis. 2022;26:835-841.
    PubMed         Abstract available

  6. TABERNERO E, Rodrigo T, Garros J, Altube L, et al
    TB in the elderly: clinical features and outcomes.
    Int J Tuberc Lung Dis. 2022;26:842-849.
    PubMed         Abstract available

  7. SCHWALB A, Cachay R, Wright A, Phillips PPJ, et al
    Factors associated with screening failure and study withdrawal in multidrug-resistant TB.
    Int J Tuberc Lung Dis. 2022;26:820-825.
    PubMed         Abstract available

  8. CHO EJ, Kang MR, Kim JH, Lee JI, et al
    Evaluation of the MolecuTech((R)) REBA MTB-XMDR kit for detection of pre-extensively drug-resistant TB.
    Int J Tuberc Lung Dis. 2022;26:869-874.
    PubMed         Abstract available

  9. SHUKLA A, Bromage S, Dholakia Y, Hemler EC, et al
    Case-control study of vitamin D status and adult multidrug-resistant pulmonary TB.
    Int J Tuberc Lung Dis. 2022;26:826-834.
    PubMed         Abstract available

  10. DURET A, Olgemoeller F, Ferreras-Antolin L, Whittaker E, et al
    Paediatric TB care in the United Kingdom.
    Int J Tuberc Lung Dis. 2022;26:814-819.
    PubMed         Abstract available

  11. SANTOS AP, Silva DR, Miranda G, Braga MS, et al
    Xpert((R)) MTB/RIF Ultra: detection of extrapulmonary TB in a high-burden setting.
    Int J Tuberc Lung Dis. 2022;26:880-882.
    PubMed        

  12. SABI I, Olomi W, Nkereuwem E, Togun T, et al
    Diagnosis of paediatric TB using Xpert((R)) MTB/RIF Ultra on fresh respiratory samples.
    Int J Tuberc Lung Dis. 2022;26:862-868.
    PubMed         Abstract available

  13. KHAN U, Guglielmetti L
    Evidence and ethical considerations for the treatment of contacts exposed to drug-resistant TB.
    Int J Tuberc Lung Dis. 2022;26:900-901.
    PubMed        

  14. MOHAPATRA PR, Mishra B, Dutta A, Bhuniya S, et al
    Responding to WHO s 4-month regimen for drug-susceptible pulmonary TB.
    Int J Tuberc Lung Dis. 2022;26:898-899.
    PubMed        

  15. FARIA N, Reis R
    Screening for TB infection: the operator s impact.
    Int J Tuberc Lung Dis. 2022;26:857-861.
    PubMed         Abstract available


    J Infect

  16. XU Y, Tan Y, Zhang X, Cheng M, et al
    Comprehensive identification of immuno-related transcriptional signature for active pulmonary tuberculosis by integrated analysis of array and single cell RNA-seq.
    J Infect. 2022 Aug 22. pii: S0163-4453(22)00501.
    PubMed         Abstract available

  17. LEE DG, Kim HJ, Park MJ, Hong JH, et al
    Proteomic analysis of sequential isolates of multidrug-resistant Mycobacterium tuberculosis during treatment failure: Altered protein expression in failed MDR-TB treatment.
    J Infect. 2022 Aug 17. pii: S0163-4453(22)00473.
    PubMed        


    PLoS One

  18. ACEN EL, Kateete DP, Worodria W, Olum R, et al
    Evaluation of circulating serum cathelicidin levels as a potential biomarker to discriminate between active and latent tuberculosis in Uganda.
    PLoS One. 2022;17:e0272788.
    PubMed         Abstract available

  19. FISCHER H, Qian L, Skarbinski J, Bruxvoort KJ, et al
    Development and validation of a prediction algorithm to identify birth in countries with high tuberculosis incidence in two large California health systems.
    PLoS One. 2022;17:e0273363.
    PubMed         Abstract available

  20. MINGCHAY P, Paitoonpong L, Kawkitinarong K, Ohata PJ, et al
    Tuberculosis at a university hospital, Thailand: A surprising incidence of TB among a new generation of highly exposed health care workers who may be asymptomatic.
    PLoS One. 2022;17:e0273027.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Tuberculosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: